Lyme disease affects an estimated 300,000 people in the United States each year. Despite its increasing prevalence, there are many lingering myths about this tick-borne illness. Also known as the “great imitator,” Lyme disease often affects more than one system in the body and can trigger a wide range of symptoms that may mimic other… Read More »
[unable to retrieve full-text content]Regular and strenuous exercise can increase the risk of MND in people who are vulnerable, scientists say. BBC News – Health
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
AstraZeneca’s diabetes med Farxiga stormed the heart failure market with a first-in-class approval last year—and in chronic kidney disease, it just left would-be rival Jardiance in the dust. The FDA late Friday approved Farxiga, also known as dapagliflozin, to treat chronic kidney disease even in patients without diabetes. With that CKD approval in hand, Farxiga… Read More »